Chronic kidney disease

@article{Levey2012ChronicKD,
  title={Chronic kidney disease},
  author={Andrew S. Levey and Josef Coresh},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={165-180}
}
Chronic Kidney Disease - An Overview
TLDR
Early identification of patients with kidney disease is recommended, as measures may be instituted to slow progression and mitigate cardiovascular risk.
Chronic kidney disease
Chronic kidney disease (CKD) is a broad term used to describe any abnormality of kidney structure or function. It is often asymptomatic in the early stages and co-exists with other chronic illnesses,
Chronic Kidney Disease in Older People.
TLDR
The solution to the public health problem of CKD is to improve strategies for prevention and treatment and tailor these strategies to each patient’s age and risk, rather than redefine CKD.
Treatment and Prevention of Common Complications of Chronic Kidney Disease
TLDR
Current recommendations from various clinical guidelines and research studies for treatment, prevention and delaying the progression of both CKD and its common complications such as hypertension, anemia, renal osteodystrophy, electrolyte and acid-base imbalance, and hyperlipidemia are outlined.
Cardiovascular Risk Factors in Patients with Chronic Kidney Disease Under Conservative Treatment
TLDR
The main cause of kidney disease is diabetic nephropathy and hypertensive nephrosclerosis, both accelerated by smoking and dyslipidemia; thus, the higher risk of CVD among CKD patients is secondary to accumulation of risk factors.
[Epidemiology of chronic kidney disease].
TLDR
It is, therefore, at the early stages of CKD that the efforts of screening and prevention of ESRD should be targeted.
Epidemiology and management of chronic renal failure: a global public health problem
TLDR
The epidemiology, diagnosis, treatment and management of chronic kidney disease is explored, suggesting that chronic renal failure is a growing issue in developed and developing countries.
The Role of Nutrition Care Process in the Addressing Health Disparities in End Stage Renal Disease
TLDR
Patients with chronic kidney disease stages 3 to 5 are at increased risk of progressing to end-stage renal disease (ESRD) or dying before the development of ESRD compared with patients with less severe Chronic kidney disease.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 134 REFERENCES
The burden of kidney disease: improving global outcomes.
TLDR
A new initiative "Kidney Disease: Improving Global Outcomes" has been established, its stated mission is to improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration and integration of initiatives to develop and implement clinical practice guidelines.
Dissecting and refining the staging of chronic kidney disease.
TLDR
A modified definition and staging system of CKD based on the presence of unequivocal, irreversible structural kidney disease, the presence or degree of impairment of kidney function, and the consequences thereof is offered for discussion.
Chronic kidney disease definition and classification: no need for a rush to judgment.
TLDR
A systematic analysis of the data accrued, since the publication of the original guideline in 2002, is necessary for the consideration of any refinement or redesign of the current staging of CKD.
Conceptual model of CKD: applications and implications.
  • A. Levey, L. Stevens, J. Coresh
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2009
The conceptual model of chronic kidney disease (CKD) was developed by the National Kidney Foundation's Kidney Disease Quality Outcome Initiative (NKF-KDOQI) in 2002 and subsequently revised and
A predictive model for progression of chronic kidney disease to kidney failure.
TLDR
A model using routinely obtained laboratory tests can accurately predict progression to kidney failure in patients with CKD stages 3 to 5, and was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria.
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
TLDR
The 2006 KDIGO Controversies Conference on CKD was convened to consider six major topics: CKD classification, CKD screening and surveillance, public policy for CKD, CVD and CVD risk factors as risk factors for development and progression of CKd, association of CKD with chronic infections, and (6) association of CJD with cancer.
Kidney Disease: Improving Global Outcomes
TLDR
The first three KDIGO guidelines—treatment of hepatitis C, management of bone and mineral disease, and care of kidney transplant recipients—have been finalized and the next three—acute kidney injury, Management of glomerulonephritis, and management of blood pressure in chronic kidney disease—are under development.
Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
TLDR
Application of CKD testing in national and international screening and surveillance programs could improve public health related to CKD and understanding the strengths and limitations of CKd testing is critical for appropriate implementation of these recommendations.
Which Antihypertensive Agents in Chronic Kidney Disease?
TLDR
This editorial compares Rahman and colleagues' results with those of previous studies in patients with chronic kidney disease that looked at the efficacy of antihypertensive agents that interrupt the reninangiotensin system, and shows that the ACE inhibitor or ARB-based regimens reduced proteinuria, slowed the decrease in GFR, and delayed the onset of kidney failure more than other regimens, even though all comparison groups achieved equivalent levels of blood pressure.
...
1
2
3
4
5
...